Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study. [PDF]
Dicpinigaitis PV +13 more
europepmc +1 more source
Refractory Chronic Cough at the Crossroads
openaire +2 more sources
Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough. [PDF]
Niimi A +6 more
europepmc +1 more source
Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series. [PDF]
Brindle K, Zhang M, Carter N, Morice AH.
europepmc +1 more source
Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. [PDF]
Zhang M +9 more
europepmc +1 more source
Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough? [PDF]
Sundar KM +3 more
europepmc +1 more source
Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough. [PDF]
Slovarp L +5 more
europepmc +1 more source
The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial. [PDF]
Wang S +7 more
europepmc +1 more source
P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough. [PDF]
Cui WW +13 more
europepmc +1 more source
Increased expression of bronchial epithelial transient receptor potential vanilloid 1 channels in severe asthma [PDF]
Agopyan +42 more
core +1 more source

